Background: Patients with pulmonary arterial hypertension (PAH) present impairments in muscle strength and exercise capacity. There is growing evidence about the benefits of neuromuscular electrical stimulation (NMES) in patients with respiratory diseases, except in patients with PAH. The aim of this study was to investigate the effects of NMES on muscle strength, and other physical and psychosocial variables in patients with PAH. Methods: Patients with PAH were randomly divided into two groups as NMES and control. The NMES was applied to the bilateral deltoid and quadriceps femoris muscles with 50 Hz for 3 days/week, 8 weeks for the NMES group. Muscle strength, muscle cross-sectional area and thickness, arterial stiffness, exercise capaci...
Background: Prevalence of COPD is common in INDIA, though there are various means used for the treat...
© 2015 The Society of Physical Therapy Science.[Purpose] This study investigated functional capacity...
Despite optimal drug treatment, many patients with CHF or COPD still suffer from disabling dyspnea, ...
Background: Patients with pulmonary arterial hypertension (PAH) present impairments in muscle streng...
Copyright © 2015 Wolters Kluwer Health, Inc.PURPOSE: The purpose of this study was to investigate th...
Pulmonary arterial hypertension is often associated with skeletal-muscle weakness. The purpose of th...
SummaryBackgroundNeuromuscular electrical stimulation (NMES) improves muscle performance and exercis...
Background: Activity levels and exercise capacity are decreased in Chronic Obstructive Pulmonary Dis...
BACKGROUND: High-frequency neuromuscular electrical stimulation increases exercise tolerance in pati...
Physical exercise is an important component in the management of pulmonary artery hypertension (PAH)...
SummaryPurposeCOPD is a condition with systemic effects of which peripheral muscle dysfunction is a ...
Chronic obstructive pulmonary disease (COPD) is a systemic disease with multiple extrapulmonary mani...
Increasing physical activity is a widely-known method of rehabilitation of patients with chronic hea...
[Purpose] This study investigated functional capacity, physical activity, and respiratory and periph...
Context: Neuromuscular electrical stimulation (NMES) combined with blood flow restriction (BFR) has ...
Background: Prevalence of COPD is common in INDIA, though there are various means used for the treat...
© 2015 The Society of Physical Therapy Science.[Purpose] This study investigated functional capacity...
Despite optimal drug treatment, many patients with CHF or COPD still suffer from disabling dyspnea, ...
Background: Patients with pulmonary arterial hypertension (PAH) present impairments in muscle streng...
Copyright © 2015 Wolters Kluwer Health, Inc.PURPOSE: The purpose of this study was to investigate th...
Pulmonary arterial hypertension is often associated with skeletal-muscle weakness. The purpose of th...
SummaryBackgroundNeuromuscular electrical stimulation (NMES) improves muscle performance and exercis...
Background: Activity levels and exercise capacity are decreased in Chronic Obstructive Pulmonary Dis...
BACKGROUND: High-frequency neuromuscular electrical stimulation increases exercise tolerance in pati...
Physical exercise is an important component in the management of pulmonary artery hypertension (PAH)...
SummaryPurposeCOPD is a condition with systemic effects of which peripheral muscle dysfunction is a ...
Chronic obstructive pulmonary disease (COPD) is a systemic disease with multiple extrapulmonary mani...
Increasing physical activity is a widely-known method of rehabilitation of patients with chronic hea...
[Purpose] This study investigated functional capacity, physical activity, and respiratory and periph...
Context: Neuromuscular electrical stimulation (NMES) combined with blood flow restriction (BFR) has ...
Background: Prevalence of COPD is common in INDIA, though there are various means used for the treat...
© 2015 The Society of Physical Therapy Science.[Purpose] This study investigated functional capacity...
Despite optimal drug treatment, many patients with CHF or COPD still suffer from disabling dyspnea, ...